Integrating post induction WT1 quantification and flow-cytometry results improves minimal residual disease stratification in acute myeloid leukemia

Carlo Marani, Marino Clavio, Raffaella Grasso, Nicoletta Colombo, Fabio Guolo, Annalisa Kunkl, Filippo Ballerini, Livia Giannoni, Chiara Ghiggi, Giuseppina Fugazza, Jean Louis Ravetti, Marco Gobbi, Maurizio Miglino

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Fifty uniformly treated adult AML patients were analyzed with respect to pre-treatment and post-induction risk factors. Forty-two patients achieving complete hematological remission were assessed for minimal residual disease (MRD) by WT1 gene expression; 34 by flow-cytometry (flow-MRD). Patients who were flow-MRD negative had a better 3-year disease-free (DFS; 79.5% vs. 27.3%; p= .032) compared with patients who were still positive after induction. Interestingly, DFS of flow-MRD positive patients was not related to the amount of flow-detected clone population (≥ or

Original languageEnglish
Pages (from-to)1606-1611
Number of pages6
JournalLeukemia Research
Volume37
Issue number12
DOIs
Publication statusPublished - Dec 2013

Fingerprint

Residual Neoplasm
Acute Myeloid Leukemia
Flow Cytometry
Clone Cells
Gene Expression
Population

Keywords

  • Acute myeloid leukemia
  • Early response assessment
  • Flow-cytometry
  • Minimal residual disease
  • Prognosis
  • Wilms' tumor gene

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Integrating post induction WT1 quantification and flow-cytometry results improves minimal residual disease stratification in acute myeloid leukemia. / Marani, Carlo; Clavio, Marino; Grasso, Raffaella; Colombo, Nicoletta; Guolo, Fabio; Kunkl, Annalisa; Ballerini, Filippo; Giannoni, Livia; Ghiggi, Chiara; Fugazza, Giuseppina; Ravetti, Jean Louis; Gobbi, Marco; Miglino, Maurizio.

In: Leukemia Research, Vol. 37, No. 12, 12.2013, p. 1606-1611.

Research output: Contribution to journalArticle

Marani, Carlo ; Clavio, Marino ; Grasso, Raffaella ; Colombo, Nicoletta ; Guolo, Fabio ; Kunkl, Annalisa ; Ballerini, Filippo ; Giannoni, Livia ; Ghiggi, Chiara ; Fugazza, Giuseppina ; Ravetti, Jean Louis ; Gobbi, Marco ; Miglino, Maurizio. / Integrating post induction WT1 quantification and flow-cytometry results improves minimal residual disease stratification in acute myeloid leukemia. In: Leukemia Research. 2013 ; Vol. 37, No. 12. pp. 1606-1611.
@article{4e4455c35ddd4046b376f9b866339776,
title = "Integrating post induction WT1 quantification and flow-cytometry results improves minimal residual disease stratification in acute myeloid leukemia",
abstract = "Fifty uniformly treated adult AML patients were analyzed with respect to pre-treatment and post-induction risk factors. Forty-two patients achieving complete hematological remission were assessed for minimal residual disease (MRD) by WT1 gene expression; 34 by flow-cytometry (flow-MRD). Patients who were flow-MRD negative had a better 3-year disease-free (DFS; 79.5{\%} vs. 27.3{\%}; p= .032) compared with patients who were still positive after induction. Interestingly, DFS of flow-MRD positive patients was not related to the amount of flow-detected clone population (≥ or",
keywords = "Acute myeloid leukemia, Early response assessment, Flow-cytometry, Minimal residual disease, Prognosis, Wilms' tumor gene",
author = "Carlo Marani and Marino Clavio and Raffaella Grasso and Nicoletta Colombo and Fabio Guolo and Annalisa Kunkl and Filippo Ballerini and Livia Giannoni and Chiara Ghiggi and Giuseppina Fugazza and Ravetti, {Jean Louis} and Marco Gobbi and Maurizio Miglino",
year = "2013",
month = "12",
doi = "10.1016/j.leukres.2013.07.005",
language = "English",
volume = "37",
pages = "1606--1611",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Ltd",
number = "12",

}

TY - JOUR

T1 - Integrating post induction WT1 quantification and flow-cytometry results improves minimal residual disease stratification in acute myeloid leukemia

AU - Marani, Carlo

AU - Clavio, Marino

AU - Grasso, Raffaella

AU - Colombo, Nicoletta

AU - Guolo, Fabio

AU - Kunkl, Annalisa

AU - Ballerini, Filippo

AU - Giannoni, Livia

AU - Ghiggi, Chiara

AU - Fugazza, Giuseppina

AU - Ravetti, Jean Louis

AU - Gobbi, Marco

AU - Miglino, Maurizio

PY - 2013/12

Y1 - 2013/12

N2 - Fifty uniformly treated adult AML patients were analyzed with respect to pre-treatment and post-induction risk factors. Forty-two patients achieving complete hematological remission were assessed for minimal residual disease (MRD) by WT1 gene expression; 34 by flow-cytometry (flow-MRD). Patients who were flow-MRD negative had a better 3-year disease-free (DFS; 79.5% vs. 27.3%; p= .032) compared with patients who were still positive after induction. Interestingly, DFS of flow-MRD positive patients was not related to the amount of flow-detected clone population (≥ or

AB - Fifty uniformly treated adult AML patients were analyzed with respect to pre-treatment and post-induction risk factors. Forty-two patients achieving complete hematological remission were assessed for minimal residual disease (MRD) by WT1 gene expression; 34 by flow-cytometry (flow-MRD). Patients who were flow-MRD negative had a better 3-year disease-free (DFS; 79.5% vs. 27.3%; p= .032) compared with patients who were still positive after induction. Interestingly, DFS of flow-MRD positive patients was not related to the amount of flow-detected clone population (≥ or

KW - Acute myeloid leukemia

KW - Early response assessment

KW - Flow-cytometry

KW - Minimal residual disease

KW - Prognosis

KW - Wilms' tumor gene

UR - http://www.scopus.com/inward/record.url?scp=84888135840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888135840&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2013.07.005

DO - 10.1016/j.leukres.2013.07.005

M3 - Article

C2 - 23891447

AN - SCOPUS:84888135840

VL - 37

SP - 1606

EP - 1611

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 12

ER -